Crohn’s & Colitis Congress® Transforming IBD Care
Join colleagues across the entire spectrum of clinical care and science at the premier conference on inflammatory bowel disease (IBD).
Join colleagues across the entire spectrum of clinical care and science at the premier conference on inflammatory bowel disease (IBD).
Objective Achieving HBV cure will require novel combination therapies of direct-acting antivirals and immunomodulatory agents. In this context, the toll-like receptor 8 (TLR8) agonist selgantolimod…
To cite: Wester A, Shang Y, Toresson Grip E, et al. Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with…
Nonanesthesiologist-administered propofol (NAAP) is increasingly accepted, but data are limited on drug administration using target-controlled infusion (TCI) in clinical practice. TCI adjusts the drug infusion…
Objective Chronic obstructive pulmonary disease (COPD) is a major cause of global illness and death, most commonly caused by cigarette smoke. The mechanisms of pathogenesis…
Research says hemostatic powder is comparable to standard-of-care methods to stop gastrointestinal bleeding, with similar safety.
Abstract: Tremendous effort has been put forth over the past 2 decades in understanding the pathophysiology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). Although multiple…
This Clinical Review outlines the challenges to optimizing bowel preparation and the importance of patient engagement in selecting a bowel preparation to improve compliance, and…
Gastrointestinal Endoscopy is pleased to present the GIE Audio and Podcasts program. Users can listen to podcasts on their computer or mp3 player by clicking…
PNPLA3 G-allele is an important determinant of disease severity in nonalcoholic fatty liver disease (NAFLD). Here, we investigated the effect of age, body mass index…
A pharmacy-based, multicomponent intervention program reduced proton pump inhibitor use overall and also when appropriate for gastroprotection, with little evidence of either clinical harms or…